Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Breast Cancer (MBC)”

238 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 238 results

Not applicableActive Not RecruitingNCT05571618
What this trial is testing

The Rechallenge of ADCs in MBC Patients

Who this might be right for
Breast Cancer
Fudan University 100
Testing effectiveness (Phase 2)Study completedNCT03213041
What this trial is testing

Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer

Who this might be right for
Estrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu Negative+4 more
Northwestern University 12
Early research (Phase 1)Study completedNCT00928330
What this trial is testing

Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based Therapy

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 57
Testing effectiveness (Phase 2)Ended earlyNCT03952325
What this trial is testing

Tesetaxel Plus 3 Different PD-(L)1 Inhibitors in Patients With Triple-Negative MBC and Tesetaxel Monotherapy in Patients With HER2-Negative MBC

Who this might be right for
Breast Cancer
Odonate Therapeutics, Inc. 294
Testing effectiveness (Phase 2)Study completedNCT00940225
What this trial is testing

Study of Cabozantinib (XL184) in Adults With Advanced Malignancies

Who this might be right for
Solid TumorsCancer
Exelixis 730
Testing effectiveness (Phase 2)Study completedNCT01908101
What this trial is testing

Eribulin Mesylate in Treating Patients With Previously Treated Metastatic Breast Cancer

Who this might be right for
Recurrent Breast CarcinomaStage IV Breast Cancer
University of Washington 86
Testing effectiveness (Phase 2)Study completedNCT00386685
What this trial is testing

XRP9881 in Combination With Trastuzumab in Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Sanofi 51
Large-scale testing (Phase 3)Study completedNCT01160211
What this trial is testing

Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 369
Large-scale testing (Phase 3)Ended earlyNCT01655992
What this trial is testing

A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Fudan University 386
Large-scale testing (Phase 3)Study completedNCT00281697
What this trial is testing

Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2)

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 684
Early research (Phase 1)Study completedNCT02001974
What this trial is testing

Pilot Study to Evaluate Reparixin With Weekly Paclitaxel in Patients With HER 2 Negative Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Dompé Farmaceutici S.p.A 33
Early research (Phase 1)Study completedNCT02223052
What this trial is testing

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Who this might be right for
Hematological NeoplasmsNon-Hodgkin's LymphomaHodgkin's Lymphoma+17 more
Celgene 89
Large-scale testing (Phase 3)Ended earlyNCT04869943
What this trial is testing

Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Veru Inc. 52
Large-scale testing (Phase 3)UnknownNCT06143553
What this trial is testing

Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer (MBC)
Shanghai Yizhong Pharmaceutical Co., Ltd. 168
Testing effectiveness (Phase 2)WithdrawnNCT01479179
What this trial is testing

Trastuzumab in Combination With AMG 479 in HER-2 Overexpressing MBC Progressing on Trastuzumab

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)UnknownNCT02344472
What this trial is testing

Detect V / CHEVENDO (Chemo vs. Endo)

Who this might be right for
Metastatic Breast Cancer
Prof. Wolfgang Janni 271
Not applicableStudy completedNCT05392985
What this trial is testing

Detection and Analysis of MBC With Heterogeneous ER Expression

Who this might be right for
Breast Cancer
Fudan University 51
Not applicableStudy completedNCT06344767
What this trial is testing

Positive ER Expression Assessed by 18F-FES PET/CT in the MBC with ER-negative Primary Tumor

Who this might be right for
Breast Cancer
Fudan University 19
Testing effectiveness (Phase 2)Study completedNCT01380808
What this trial is testing

Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Fudan University 100
Early research (Phase 1)WithdrawnNCT04872608
What this trial is testing

Letrozole, Palbociclib, and Onapristone ER in People With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerUnresectable Breast Cancer
Memorial Sloan Kettering Cancer Center
Next Page